PARP9
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
PARP9 antibody can be used for detection of PARP9 by ELISA at 1:62500. PARP9 antibody can be used for detection of PARP9 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.
Konzentration
1 mg/mL
Buffer
Antibody is lyophilized in PBS buffer with 2 % sucrose.
Handhabung
As with any antibody avoid repeat freeze-thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
For short periods of storage (days) store at 4 °C. For longer periods of storage, store PARP9 antibody at -20 °C.
Target
PARP9
(Poly (ADP-Ribose) Polymerase Family, Member 9 (PARP9))
RGD1307534 antikoerper, ARTD9 antikoerper, BAL antikoerper, BAL1 antikoerper, MGC:7868 antikoerper, AW214463 antikoerper, BC003281 antikoerper, Bagl antikoerper, Bal antikoerper, PARP-9 antikoerper, poly (ADP-ribose) polymerase family, member 9 antikoerper, poly(ADP-ribose) polymerase family member 9 antikoerper, si:ch211-219a4.6 antikoerper, Parp9 antikoerper, PARP9 antikoerper, si:ch211-219a4.6 antikoerper
Hintergrund
PARP9 contains 2 Macro domains and 1 PARP catalytic domain. PARP9 is overexpressed at significantly higher levels in fatal high-risk diffuse large B-cell lymphomas (DLB-CL) compared to cured low-risk tumors. Overexpression of PARP9 in B-cell lymphoma transfectants may promote malignant B-cell migration. The function of PARP9 remains unknown.